Skip to main content

Table 1 Baseline characteristics of patient subjects at the start of DPO CERA treatment

From: Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients

  At the time of DPO treatment At the time of CERA treatment P value
Hemoglobin (g/dL) 10.5 ± 0.34 10.4 ± 0.75 0.799
Serum iron (μg/dL) 82.4 ± 26.34 89.3 ± 26.62 0.447
Serum ferritin (ng/mL) 160.69 ± 66.84 163.67 ± 67.40 0.612
TSAT (%) 45.3 ± 17.82 39.8 ± 9.44 0.311
Hepcidin (ng/mL) 98.9 ± 35.42 79.3 ± 27.95 0.176
hs-CRP (mg/dL) 0.19 ± 6.81 0.07 ± 5.01 0.112
Albumin (g/dL) 3.5 ± 0.29 3.7 ± 0.22 0.106
Body weight (kg) 57.9 ± 5.2 58.2 ± 5.0 0.229
ΔBody weight (kg)a 0.07 ± 0.45 0.30 ± 0.56 0.501
  1. Sex (M/F, n) is 3/4
  2. The age (years) is 72.3 ± 7.63
  3. The hemodialysis duration (months) is 66.9 ± 60.9
  4. aIs the change of body weight during the 14 days of DPO and CERA treatment